RajivDhawanMD
Cardiology • Hanover, PAAdult Congenital Heart Disease, Interventional Cardiology
Physician
Dr. Dhawan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 Stock St
Ste 3
Hanover, PA 17331Phone+1 717-637-1738
Education & Training
Main Line Health System/Lankenau Medical CenterFellowship, Interventional Cardiology, 2001 - 2002
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1995 - 1998
Delhi University College of Medical SciencesClass of 1985
Certifications & Licensure
DE State Medical License 2022 - 2025
OH State Medical License 2023 - 2025
MD State Medical License 2023 - 2024
PA State Medical License 1996 - 2024
NJ State Medical License 2002 - 2005- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 16 citationsE-CART (ElectroCautery-Assisted Re-enTry) of an Aorto-Ostial Right Coronary Artery Chronic Total Occlusion: First-in-Man.William J. Nicholson, James Harvey, Rajiv Dhawan
JACC. Cardiovascular Interventions. 2016-11-28 - 13 citationsAcute renal infarction secondary to left ventricular thrombus, masquerading as a renal calculus--a case report and brief review of literature.Gurdev Singh, Rajiv Dhawan, Chad E. Potteiger, Ashwani Bedi, Thomas A. Modesto
Angiology. 2001-10-01 - 56 citationsSpontaneous coronary artery dissection: The clinical spectrumRajiv Dhawan, Gurdev Singh, Henry Fesniak
Angiology. 2002-01-01
Press Mentions
In India, Black Markets for Tocilizumab Spring up as Demand for the Covid-19 Drug SurgesJuly 7th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
